ePharmacy Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

Description

The global ePharmacy market, which witnessed sales of US$ 99 billion in 2024, is poised for extraordinary growth in the coming decade, according to the latest report from Fairfield Market Research. The ePharmacy sector is on track to outpace historical growth rates, offering an absolute dollar opportunity of US$ 510 billion during the forecast period.

Rising Internet Penetration Drives Growth

The primary driver behind the robust growth of the ePharmacy market is the increasing ubiquity of the internet. As internet penetration continues to expand globally, online pharmacies have flourished, offering consumers the convenience of purchasing medications and prescription devices through both online and traditional brick-and-mortar channels. These online pharmacies fulfill on-demand orders placed over the internet and provide prescription deliveries through mail services.

Government Initiatives Promote Healthcare Infrastructure

Government initiatives aimed at enhancing the efficiency and effectiveness of public healthcare systems have played a pivotal role in propelling the ePharmacy market forward. Notable examples include India's National Health Portal, Online registering system, e-hospital@NIC, and the Central Drugs Standards Control Organization (SUGAM). Moreover, the Union Cabinet of India's approval of amending the existing Foreign Direct Investment (FDI) law in the pharmaceutical sector to 100% has further facilitated drug production and the manufacturing of life-saving medicines.

Key Regions of Opportunity

The Asia-Pacific (APAC) region is emerging as a hotspot for ePharmacy market growth, with several major companies expanding their production units across different APAC locations to enhance distribution efficiency. This shift in diversification offers substantial opportunities for the ePharmacy market.

U.S. ePharmacy Market Thrives on Healthcare Access

The United States, with its growing number of hospital admissions and favorable medicare reimbursement policies, is a key contributor to the global ePharmacy market's success. CVS Pharmacy, a leading specialty drug pharmacy in the U.S., has significantly expanded its presence in recent years, reflecting the dynamic changes in the pharmacy industry.

U.K. ePharmacy Market on a Growth Trajectory

The U.K. ePharmacy market is on track to achieve remarkable growth, with a substantial market size anticipated by 2033. A projected CAGR from 2024 to 2033 is expected to create substantial absolute dollar opportunities during this period.

Competitive Landscape Analysis

1. The Kroger Co.
2. Walgreen Co.
3. Giant Eagle Inc.
4. Walmart Inc.
5. Express Scripts Holding Company
6. CVS Health
7. Optum Rx Inc.
8. Rowlands Pharmacy
9. DocMorris (Zur Rose Group AG)

Market Segments Covered in ePharmacy Industry Analysis

By Pharmacy Size

Large
Medium
Small

By Region

North America
Latin America
Europe
APAC
MEA

1. Executive Summary

1.1. Global ePharmacy Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2023
1.5. Analyst Recommendations

2. Market Overview

2.1. Market Definitions and Segmentations
2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter's Five Forces Analysis
2.5. COVID-19 Impact Analysis
- 2.5.1. Supply
- 2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
- 2.7.1. World Economic Projections
2.8. PESTLE Analysis

3. Global ePharmacy Market Outlook, 2018 - 2031

3.1. Global ePharmacy Market Outlook, by Pharmacy Size (US$ Bn), 2018 - 2031
- 3.1.1. Key Highlights
  - 3.1.1.1. Large
  - 3.1.1.2. Medium
  - 3.1.1.3. Small
3.2. Global ePharmacy Market Outlook, by Product, Value (US$ Bn), 2018 - 2031
- 3.2.1. Key Highlights
  - 3.2.1.1. Over the Counter Product
  - 3.2.1.2. Prescription Medicines
3.3. Global ePharmacy Market Outlook, by Region, Value (US$ Bn), 2018 - 2031
- 3.3.1. Key Highlights
  - 3.3.1.1. North America
  - 3.3.1.2. Europe
  - 3.3.1.3. Asia Pacific
  - 3.3.1.4. Latin America
  - 3.3.1.5. Middle East & Africa

4. North America ePharmacy Market Outlook, 2018 - 2031

4.1. North America ePharmacy Market Outlook, by Pharmacy Size (US$ Bn), 2018 - 2031
- 4.1.1. Key Highlights
  - 4.1.1.1. Large
  - 4.1.1.2. Medium
  - 4.1.1.3. Small
4.2. North America ePharmacy Market Outlook, by Product, Value (US$ Bn), 2018 - 2031
- 4.2.1. Key Highlights
  - 4.2.1.1. Over the Counter Product
  - 4.2.1.2. Prescription Medicines
- 4.2.2. BPS Analysis/Market Attractiveness Analysis
4.3. North America ePharmacy Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
- 4.3.1. Key Highlights
  - 4.3.1.1. U.S. ePharmacy Market by Pharmacy Size (US$ Bn), 2018 - 2031
  - 4.3.1.2. U.S. ePharmacy Market by Product, Value (US$ Bn), 2018 - 2031
  - 4.3.1.3. Canada ePharmacy Market by Pharmacy Size (US$ Bn), 2018 - 2031
  - 4.3.1.4. Canada ePharmacy Market by Product, Value (US$ Bn), 2018 - 2031
- 4.3.2. BPS Analysis/Market Attractiveness Analysis

5. Europe ePharmacy Market Outlook, 2018 - 2031

5.1. Europe ePharmacy Market Outlook, by Pharmacy Size (US$ Bn), 2018 - 2031
- 5.1.1. Key Highlights
  - 5.1.1.1. Large
  - 5.1.1.2. Medium
  - 5.1.1.3. Small
5.2. Europe ePharmacy Market Outlook, by Product, Value (US$ Bn), 2018 - 2031
- 5.2.1. Key Highlights
  - 5.2.1.1. Over the Counter Product
  - 5.2.1.2. Prescription Medicines
- 5.2.2. BPS Analysis/Market Attractiveness Analysis
5.3. Europe ePharmacy Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
- 5.3.1. Key Highlights
  - 5.3.1.1. Germany ePharmacy Market by Pharmacy Size (US$ Bn), 2018 - 2031
  - 5.3.1.2. Germany ePharmacy Market by Product, Value (US$ Bn), 2018 - 2031
  - 5.3.1.3. U.K. ePharmacy Market by Pharmacy Size (US$ Bn), 2018 - 2031
  - 5.3.1.4. U.K. ePharmacy Market by Product, Value (US$ Bn), 2018 - 2031
  - 5.3.1.5. France ePharmacy Market by Pharmacy Size (US$ Bn), 2018 - 2031
  - 5.3.1.6. France ePharmacy Market by Product, Value (US$ Bn), 2018 - 2031
  - 5.3.1.7. Italy ePharmacy Market by Pharmacy Size (US$ Bn), 2018 - 2031
  - 5.3.1.8. Italy ePharmacy Market by Product, Value (US$ Bn), 2018 - 2031
  - 5.3.1.9. Turkey ePharmacy Market by Pharmacy Size (US$ Bn), 2018 - 2031
  - 5.3.1.10. Turkey ePharmacy Market by Product, Value (US$ Bn), 2018 - 2031
  - 5.3.1.11. Russia ePharmacy Market by Pharmacy Size (US$ Bn), 2018 - 2031
  - 5.3.1.12. Russia ePharmacy Market by Product, Value (US$ Bn), 2018 - 2031
  - 5.3.1.13. Rest of Europe ePharmacy Market by Pharmacy Size (US$ Bn), 2018 - 2031
  - 5.3.1.14. Rest of Europe ePharmacy Market by Product, Value (US$ Bn), 2018 - 2031
- 5.3.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific ePharmacy Market Outlook, 2018 - 2031

6.1. Asia Pacific ePharmacy Market Outlook, by Pharmacy Size (US$ Bn), 2018 - 2031
- 6.1.1. Key Highlights
  - 6.1.1.1. Large
  - 6.1.1.2. Medium
  - 6.1.1.3. Small
6.2. Asia Pacific ePharmacy Market Outlook, by Product, Value (US$ Bn), 2018 - 2031
- 6.2.1. Key Highlights
  - 6.2.1.1. Over the Counter Product
  - 6.2.1.2. Prescription Medicines
- 6.2.2. Others BPS Analysis/Market Attractiveness Analysis
6.3. Asia Pacific ePharmacy Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
- 6.3.1. Key Highlights
  - 6.3.1.1. China ePharmacy Market by Pharmacy Size (US$ Bn), 2018 - 2031
  - 6.3.1.2. China ePharmacy Market by Product, Value (US$ Bn), 2018 - 2031
  - 6.3.1.3. Japan ePharmacy Market by Pharmacy Size (US$ Bn), 2018 - 2031
  - 6.3.1.4. Japan ePharmacy Market by Product, Value (US$ Bn), 2018 - 2031
  - 6.3.1.5. South Korea ePharmacy Market by Pharmacy Size (US$ Bn), 2018 - 2031
  - 6.3.1.6. South Korea ePharmacy Market by Product, Value (US$ Bn), 2018 - 2031
  - 6.3.1.7. India ePharmacy Market by Pharmacy Size (US$ Bn), 2018 - 2031
  - 6.3.1.8. India ePharmacy Market by Product, Value (US$ Bn), 2018 - 2031
  - 6.3.1.9. Southeast Asia ePharmacy Market by Pharmacy Size (US$ Bn), 2018 - 2031
  - 6.3.1.10. Southeast Asia ePharmacy Market by Product, Value (US$ Bn), 2018 - 2031
  - 6.3.1.11. Rest of Asia Pacific ePharmacy Market by Pharmacy Size (US$ Bn), 2018 - 2031
  - 6.3.1.12. Rest of Asia Pacific ePharmacy Market by Product, Value (US$ Bn), 2018 - 2031
- 6.3.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America ePharmacy Market Outlook, 2018 - 2031

7.1. Latin America ePharmacy Market Outlook, by Pharmacy Size (US$ Bn), 2018 - 2031
- 7.1.1. Key Highlights
  - 7.1.1.1. Large
  - 7.1.1.2. Medium
  - 7.1.1.3. Small
7.2. Latin America ePharmacy Market Outlook, by Product, Value (US$ Bn), 2018 - 2031
- 7.2.2. BPS Analysis/Market Attractiveness Analysis
7.3. Latin America ePharmacy Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
- 7.3.1. Key Highlights
  - 7.3.1.1. Brazil ePharmacy Market by Pharmacy Size (US$ Bn), 2018 - 2031
  - 7.3.1.2. Brazil ePharmacy Market by Product, Value (US$ Bn), 2018 - 2031
  - 7.3.1.3. Mexico ePharmacy Market by Pharmacy Size (US$ Bn), 2018 - 2031
  - 7.3.1.4. Mexico ePharmacy Market by Product, Value (US$ Bn), 2018 - 2031
  - 7.3.1.5. Argentina ePharmacy Market by Pharmacy Size (US$ Bn), 2018 - 2031
  - 7.3.1.6. Argentina ePharmacy Market by Product, Value (US$ Bn), 2018 - 2031
  - 7.3.1.7. Rest of Latin America ePharmacy Market by Pharmacy Size (US$ Bn), 2018 - 2031
  - 7.3.1.8. Rest of Latin America ePharmacy Market by Product, Value (US$ Bn), 2018 - 2031
- 7.3.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa ePharmacy Market Outlook, 2018 - 2031

8.1. Middle East & Africa ePharmacy Market Outlook, by Pharmacy Size (US$ Bn), 2018 - 2031
- 8.1.1. Key Highlights
  - 8.1.1.1. Large
  - 8.1.1.2. Medium
  - 8.1.1.3. Small
8.2. Middle East & Africa ePharmacy Market Outlook, by Product, Value (US$ Bn), 2018 - 2031
- 8.2.1. Key Highlights
  - 8.2.1.1. Over the Counter Product
  - 8.2.1.2. Prescription Medicines
- 8.2.2. BPS Analysis/Market Attractiveness Analysis
8.3. Middle East & Africa ePharmacy Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
- 8.3.1. Key Highlights
  - 8.3.1.1. GCC ePharmacy Market by Pharmacy Size (US$ Bn), 2018 - 2031
  - 8.3.1.2. GCC ePharmacy Market by Product, Value (US$ Bn), 2018 - 2031
  - 8.3.1.3. South Africa ePharmacy Market by Pharmacy Size (US$ Bn), 2018 - 2031
  - 8.3.1.4. South Africa ePharmacy Market by Product, Value (US$ Bn), 2018 - 2031
  - 8.3.1.5. Egypt ePharmacy Market by Pharmacy Size (US$ Bn), 2018 - 2031
  - 8.3.1.6. Egypt ePharmacy Market by Product, Value (US$ Bn), 2018 - 2031
  - 8.3.1.7. Nigeria ePharmacy Market by Pharmacy Size (US$ Bn), 2018 - 2031
  - 8.3.1.8. Nigeria ePharmacy Market by Product, Value (US$ Bn), 2018 - 2031
  - 8.3.1.9. Rest of Middle East & Africa ePharmacy Market by Pharmacy Size (US$ Bn), 2018 - 2031
  - 8.3.1.10. Rest of Middle East & Africa ePharmacy Market by Product, Value (US$ Bn), 2018 - 2031
- 8.3.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

9.1. Manufacturer vs by Product Heatmap
9.2. Company Market Share Analysis, 2023
9.3. Competitive Dashboard
9.4. Company Profiles
- 9.4.1. The Kroger Co.
  - 9.4.1.1. Company Overview
  - 9.4.1.2. Product Portfolio
  - 9.4.1.3. Financial Overview
  - 9.4.1.4. Business Strategies and Development
- 9.4.2. Walgreen Co.
  - 9.4.2.1. Company Overview
  - 9.4.2.2. Product Portfolio
  - 9.4.2.3. Financial Overview
  - 9.4.2.4. Business Strategies and Development
- 9.4.3. Giant Eagle, Inc.
  - 9.4.3.1. Company Overview
  - 9.4.3.2. Product Portfolio
  - 9.4.3.3. Financial Overview
  - 9.4.3.4. Business Strategies and Development
- 9.4.4. Walmart, Inc.
  - 9.4.4.1. Company Overview
  - 9.4.4.2. Product Portfolio
  - 9.4.4.3. Financial Overview
  - 9.4.4.4. Business Strategies and Development
- 9.4.5. Express Scripts Holding Company
  - 9.4.5.1. Company Overview
  - 9.4.5.2. Product Portfolio
  - 9.4.5.3. Financial Overview
  - 9.4.5.4. Business Strategies and Development
- 9.4.6. CVS Health
  - 9.4.6.1. Company Overview
  - 9.4.6.2. Product Portfolio
  - 9.4.6.3. Financial Overview
  - 9.4.6.4. Business Strategies and Development
- 9.4.7. Optum Rx, Inc.
  - 9.4.7.1. Company Overview
  - 9.4.7.2. Product Portfolio
  - 9.4.7.3. Financial Overview
  - 9.4.7.4. Business Strategies and Development
- 9.4.8. Rowlands Pharmacy
  - 9.4.8.1. Company Overview
  - 9.4.8.2. Product Portfolio
  - 9.4.8.3. Financial Overview
  - 9.4.8.4. Business Strategies and Development
- 9.4.9. Docmorris (Zur Rose Group Ag)
  - 9.4.9.1. Company Overview
  - 9.4.9.2. Product Portfolio
  - 9.4.9.3. Financial Overview
  - 9.4.9.4. Business Strategies and Development

10. Appendix

10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations